CD8A and non-small cell lung carcinoma: Our data not only demonstrate that NSCLC platelet TLT-1 suppresses CD8 T cells but also provides direct evidence that extracellular TLT-1 can be targeted using an antibody-based therapeutic approach to prevent platelet-mediated suppression of patient CD8 T cells in NSCLC.